Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
Amivantamab
Amivantamab
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
Rybrevant 1600 mg, 2240 mg, 2400 mg and 3520 mg solution for injection
New
SPC
PIL
No
A
Amivantamab
Janssen Sciences Ireland (a Johnson & Johnson Company)
Rybrevant 350 mg concentrate for solution for infusion
No Recent Update
SPC
PIL
No
A
Amivantamab
Janssen Sciences Ireland (a Johnson & Johnson Company)
Cookies
